FMC Aguadilla Dialysis Center in Aguadilla, Puerto Rico - Dialysis Center

FMC Aguadilla Dialysis Center is a medicare approved dialysis facility center in Aguadilla, Puerto Rico and it has 23 dialysis stations. It is located in Aguadilla county at Carr 459 Km 0.7 Bo Camaseyes, Aguadilla, PR, 00603. You can reach out to the office of FMC Aguadilla Dialysis Center at (787) 882-1212. This dialysis clinic is managed and/or owned by Fresenius Medical Care. FMC Aguadilla Dialysis Center has the following ownership type - Profit. It was first certified by medicare in October, 1990. The medicare id for this facility is 402513 and it accepts patients under medicare ESRD program.

Dialysis Center Profile

NameFMC Aguadilla Dialysis Center
LocationCarr 459 Km 0.7 Bo Camaseyes, Aguadilla, Puerto Rico
No. of Dialysis Stations 23
Medicare ID402513
Managed ByFresenius Medical Care
Ownership TypeProfit
Late Shifts Yes

Contact Information


Carr 459 Km 0.7 Bo Camaseyes, Aguadilla, Puerto Rico, 00603
(787) 882-1212
Not Available

News Archive

Top scientists to attend 3rd annual Helmholtz-Nature Medicine Diabetes Conference

As a unique scientific panel it brings together top scientists as well as promising young researchers from different disciplines in a personal and selected ambience.

Breakthrough discovery reveals positive correlation between sugar and cancer

A nine-year joint research project conducted by VIB, KU Leuven and VUB has led to a crucial breakthrough in cancer research.

State roundup: Calif. report card shows improved care for kids

The latest developments in health policy from California, the District of Columbia, Georgia, Maryland, Minnesota, Oregon and Texas.

Quinnova Pharmaceuticals raises $17.4 million through Series B financing

Safeguard Scientifics, Inc., a holding company that builds value in growth-stage life sciences and technology companies, today announced it led a $17.4 million Series B financing round for Quinnova Pharmaceuticals, Inc., with participation from existing investors Thomas, McNerney & Partners and H.I.G. BioVentures.

Analysis: Keto diets place pregnant women and kidney disease patients at risk of adverse health effects

In the most comprehensive analysis yet of ketogenic (keto) diets, a review in Frontiers in Nutrition finds keto diets place pregnant women and kidney disease patients at risk of adverse health effects.

Read more Medical News

› Verified 2 days ago


Map and Direction



NPI Associated with this Dialysis Facility:

Dialysis Facilities may have multiple NPI numbers. We have found possible NPI number/s associated with FMC Aguadilla Dialysis Center from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number1447359864
Organization NameBma Aguadilla
Doing Business AsBio-medical Applications Of Aguadilla, Inc.
AddressRoad #459, Km. 0.7 Aguadilla, Puerto Rico, 00605
Phone Number(787) 882-1212

News Archive

Top scientists to attend 3rd annual Helmholtz-Nature Medicine Diabetes Conference

As a unique scientific panel it brings together top scientists as well as promising young researchers from different disciplines in a personal and selected ambience.

Breakthrough discovery reveals positive correlation between sugar and cancer

A nine-year joint research project conducted by VIB, KU Leuven and VUB has led to a crucial breakthrough in cancer research.

State roundup: Calif. report card shows improved care for kids

The latest developments in health policy from California, the District of Columbia, Georgia, Maryland, Minnesota, Oregon and Texas.

Quinnova Pharmaceuticals raises $17.4 million through Series B financing

Safeguard Scientifics, Inc., a holding company that builds value in growth-stage life sciences and technology companies, today announced it led a $17.4 million Series B financing round for Quinnova Pharmaceuticals, Inc., with participation from existing investors Thomas, McNerney & Partners and H.I.G. BioVentures.

Analysis: Keto diets place pregnant women and kidney disease patients at risk of adverse health effects

In the most comprehensive analysis yet of ketogenic (keto) diets, a review in Frontiers in Nutrition finds keto diets place pregnant women and kidney disease patients at risk of adverse health effects.

Read more Medical News

› Verified 2 days ago


Patient Distribution

Anemia Management

Dialysis patients with Hemoglobin data56

News Archive

Top scientists to attend 3rd annual Helmholtz-Nature Medicine Diabetes Conference

As a unique scientific panel it brings together top scientists as well as promising young researchers from different disciplines in a personal and selected ambience.

Breakthrough discovery reveals positive correlation between sugar and cancer

A nine-year joint research project conducted by VIB, KU Leuven and VUB has led to a crucial breakthrough in cancer research.

State roundup: Calif. report card shows improved care for kids

The latest developments in health policy from California, the District of Columbia, Georgia, Maryland, Minnesota, Oregon and Texas.

Quinnova Pharmaceuticals raises $17.4 million through Series B financing

Safeguard Scientifics, Inc., a holding company that builds value in growth-stage life sciences and technology companies, today announced it led a $17.4 million Series B financing round for Quinnova Pharmaceuticals, Inc., with participation from existing investors Thomas, McNerney & Partners and H.I.G. BioVentures.

Analysis: Keto diets place pregnant women and kidney disease patients at risk of adverse health effects

In the most comprehensive analysis yet of ketogenic (keto) diets, a review in Frontiers in Nutrition finds keto diets place pregnant women and kidney disease patients at risk of adverse health effects.

Read more Medical News

› Verified 2 days ago

Dialysis Adequacy

Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.

  • Hemodialysis
    Adult patients getting regular hemodialysis at the center92
    Adult patient months included in Kt/V greater than or equal to 1.2808
    Percentage of adult patients getting regular hemodialysis at the center
    Percentage of pediatric patients getting regular hemodialysis at the center

    News Archive

    Top scientists to attend 3rd annual Helmholtz-Nature Medicine Diabetes Conference

    As a unique scientific panel it brings together top scientists as well as promising young researchers from different disciplines in a personal and selected ambience.

    Breakthrough discovery reveals positive correlation between sugar and cancer

    A nine-year joint research project conducted by VIB, KU Leuven and VUB has led to a crucial breakthrough in cancer research.

    State roundup: Calif. report card shows improved care for kids

    The latest developments in health policy from California, the District of Columbia, Georgia, Maryland, Minnesota, Oregon and Texas.

    Quinnova Pharmaceuticals raises $17.4 million through Series B financing

    Safeguard Scientifics, Inc., a holding company that builds value in growth-stage life sciences and technology companies, today announced it led a $17.4 million Series B financing round for Quinnova Pharmaceuticals, Inc., with participation from existing investors Thomas, McNerney & Partners and H.I.G. BioVentures.

    Analysis: Keto diets place pregnant women and kidney disease patients at risk of adverse health effects

    In the most comprehensive analysis yet of ketogenic (keto) diets, a review in Frontiers in Nutrition finds keto diets place pregnant women and kidney disease patients at risk of adverse health effects.

    Read more Medical News

    › Verified 2 days ago

  • Peritoneal Dialysis
    Adult patients getting regular peritoneal dialysis at the center34
    Adult patient months included in Kt/V greater than or equal to 1.7303
    Percentage of adult patients getting regular peritoneal dialysis at the center
    Percentage of pediatric patients getting regular peritoneal dialysis at the center

    News Archive

    Top scientists to attend 3rd annual Helmholtz-Nature Medicine Diabetes Conference

    As a unique scientific panel it brings together top scientists as well as promising young researchers from different disciplines in a personal and selected ambience.

    Breakthrough discovery reveals positive correlation between sugar and cancer

    A nine-year joint research project conducted by VIB, KU Leuven and VUB has led to a crucial breakthrough in cancer research.

    State roundup: Calif. report card shows improved care for kids

    The latest developments in health policy from California, the District of Columbia, Georgia, Maryland, Minnesota, Oregon and Texas.

    Quinnova Pharmaceuticals raises $17.4 million through Series B financing

    Safeguard Scientifics, Inc., a holding company that builds value in growth-stage life sciences and technology companies, today announced it led a $17.4 million Series B financing round for Quinnova Pharmaceuticals, Inc., with participation from existing investors Thomas, McNerney & Partners and H.I.G. BioVentures.

    Analysis: Keto diets place pregnant women and kidney disease patients at risk of adverse health effects

    In the most comprehensive analysis yet of ketogenic (keto) diets, a review in Frontiers in Nutrition finds keto diets place pregnant women and kidney disease patients at risk of adverse health effects.

    Read more Medical News

    › Verified 2 days ago

Mineral and Bone Disorder

An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at FMC Aguadilla Dialysis Center with elevated calcium levels.

Patients with hypercalcemia146
Hypercalcemia patient months1333
Hypercalcemia patients with serumcalcium greater than 10.2 mg
Patients with Serumphosphor156
Patients with Serumphosphor less than 3.5 mg/dL
Patients with Serumphosphor from 3.5 to 4.5 mg/dL
Patients with Serumphosphor from 4.6 to 5.5 mg/dL
Patients with Serumphosphor from 5.6 to 7 mg/dL
Patients with Serumphosphor greater than 7 mg/dL

News Archive

Top scientists to attend 3rd annual Helmholtz-Nature Medicine Diabetes Conference

As a unique scientific panel it brings together top scientists as well as promising young researchers from different disciplines in a personal and selected ambience.

Breakthrough discovery reveals positive correlation between sugar and cancer

A nine-year joint research project conducted by VIB, KU Leuven and VUB has led to a crucial breakthrough in cancer research.

State roundup: Calif. report card shows improved care for kids

The latest developments in health policy from California, the District of Columbia, Georgia, Maryland, Minnesota, Oregon and Texas.

Quinnova Pharmaceuticals raises $17.4 million through Series B financing

Safeguard Scientifics, Inc., a holding company that builds value in growth-stage life sciences and technology companies, today announced it led a $17.4 million Series B financing round for Quinnova Pharmaceuticals, Inc., with participation from existing investors Thomas, McNerney & Partners and H.I.G. BioVentures.

Analysis: Keto diets place pregnant women and kidney disease patients at risk of adverse health effects

In the most comprehensive analysis yet of ketogenic (keto) diets, a review in Frontiers in Nutrition finds keto diets place pregnant women and kidney disease patients at risk of adverse health effects.

Read more Medical News

› Verified 2 days ago

Vascular Access

The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.

Patients included in arterial venous fistula and catheter summaries 86
Patient months included in arterial venous fistula and catheter summaries 651
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer

News Archive

Top scientists to attend 3rd annual Helmholtz-Nature Medicine Diabetes Conference

As a unique scientific panel it brings together top scientists as well as promising young researchers from different disciplines in a personal and selected ambience.

Breakthrough discovery reveals positive correlation between sugar and cancer

A nine-year joint research project conducted by VIB, KU Leuven and VUB has led to a crucial breakthrough in cancer research.

State roundup: Calif. report card shows improved care for kids

The latest developments in health policy from California, the District of Columbia, Georgia, Maryland, Minnesota, Oregon and Texas.

Quinnova Pharmaceuticals raises $17.4 million through Series B financing

Safeguard Scientifics, Inc., a holding company that builds value in growth-stage life sciences and technology companies, today announced it led a $17.4 million Series B financing round for Quinnova Pharmaceuticals, Inc., with participation from existing investors Thomas, McNerney & Partners and H.I.G. BioVentures.

Analysis: Keto diets place pregnant women and kidney disease patients at risk of adverse health effects

In the most comprehensive analysis yet of ketogenic (keto) diets, a review in Frontiers in Nutrition finds keto diets place pregnant women and kidney disease patients at risk of adverse health effects.

Read more Medical News

› Verified 2 days ago

Hospitalization Rate

The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.

Standard Hospitalization Summary Ratio(SHR) YearJanuary, 2016 - December, 2016
Patients in facility's Hospitalization Summary
Hospitalization Rate in facility (Not Available)
Hospitalization Rate: Upper Confidence Limit
Hospitalization Rate: Lower Confidence Limit

News Archive

Top scientists to attend 3rd annual Helmholtz-Nature Medicine Diabetes Conference

As a unique scientific panel it brings together top scientists as well as promising young researchers from different disciplines in a personal and selected ambience.

Breakthrough discovery reveals positive correlation between sugar and cancer

A nine-year joint research project conducted by VIB, KU Leuven and VUB has led to a crucial breakthrough in cancer research.

State roundup: Calif. report card shows improved care for kids

The latest developments in health policy from California, the District of Columbia, Georgia, Maryland, Minnesota, Oregon and Texas.

Quinnova Pharmaceuticals raises $17.4 million through Series B financing

Safeguard Scientifics, Inc., a holding company that builds value in growth-stage life sciences and technology companies, today announced it led a $17.4 million Series B financing round for Quinnova Pharmaceuticals, Inc., with participation from existing investors Thomas, McNerney & Partners and H.I.G. BioVentures.

Analysis: Keto diets place pregnant women and kidney disease patients at risk of adverse health effects

In the most comprehensive analysis yet of ketogenic (keto) diets, a review in Frontiers in Nutrition finds keto diets place pregnant women and kidney disease patients at risk of adverse health effects.

Read more Medical News

› Verified 2 days ago